Neurones (NRO) Q4 2025 TU earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 TU earnings summary
11 Feb, 2026Executive summary
Annual revenue reached €857.2 million in 2025, surpassing expectations.
Organic growth for the year was 5.1%, with total growth at 5.8% year-over-year.
Digital and data projects saw double-digit growth, and AI-related activities showed a strong upward trend.
The group benefited from a more favorable environment at year-end.
Financial highlights
Q4 2025 revenues were €225 million, up 6.5% year-over-year, with 6.2% organic growth.
Operating profit margin improved from 7.8% in H1 to 9.8% in H2; full-year margin at 8.8% (audited).
Average workforce increased by 280 people in 2025 to support growth.
Outlook and guidance
Market conditions are expected to be more buoyant in the coming year.
Forecasts for the current year will be announced with Q1 revenues.
Latest events from Neurones
- Organic growth hit 8% in Q2 2026, boosting H1 revenues and profit margin year-over-year.NRO
Q2 2026 TU - Q1 2026 delivered 5.6% organic growth and a higher 9% operating margin, led by digital projects.NRO
Q1 2026 TU - 2025 revenue up 5.8%, operating margin at 10.4%, and dividend set to rise 7.7%.NRO
Q4 2025 - Q3 2025 delivered 5.1% organic growth and improved margins, with robust digital segment gains.NRO
Q3 2025 - Revenue up 5.4% to €424.3M; margin improved; FY guidance raised to €850M.NRO
Q2 2025 - Organic growth of 5.3% in Q2 2025 drives raised full-year revenue guidance.NRO
Q2 2025 TU - Revenue up 9.1% in H1 2024, with strong growth in Data and Cloud services.NRO
Q2 2024 TU - Revenue up 9.1% in H1 2024; full-year guidance for €800m revenue and 9.5% margin reaffirmed.NRO
H1 2024 - Q3 2024 organic growth reached 10.5%, with 2024 guidance reaffirmed.NRO
Q3 2024 TU